T10694 |
CB1 inverse agonist 1
|
852315-00-5
|
98%
|
|
CB1 inverse agonist 1 is an orally active and selective CB1 agonist. The IC50s for CB1 and CB2 are 7.5 nM and 4100 nM, respectively. CB1 inverse agonist 1 shows ...
|
T13081 |
Taranabant racemate
|
701977-00-6
|
98%
|
|
Taranabant racemate is an antagonist and/or inverse agonist of the Cannabinoid-1 (CB1) receptor.
|
T64371 |
Virodhamine
|
|
98%
|
|
Virodhamine, an endocannabinoid, is an antagonist of CB1 receptor and an agonist of CB2 receptor. Virodhamine can be used for the research of neurological disord...
|
T14504 |
BAY 38-7271
|
212188-60-8
|
98%
|
|
BAY 38-7271 has strong neuroprotective properties.[1] BAY 38-7271 is selective and highly potent and cannabinoid CB1/CB2 receptor agonist. With Kis of 1.85 nM an...
|
T10510 |
CB1 antagonist 1
|
890037-68-0
|
98%
|
|
CB1 antagonist 1 is a CB1 receptor antagonist, used in the research of obesity and metabolic syndrome, neuroinflammatory disorders, cognitive disorders, and gast...
|
T17027 |
Tedalinab
|
916591-01-0
|
98%
|
|
Tedalinab is an effective and selective cannabinoid receptor 2 agonist. Tedalinab has the potential for neuropathic pain and osteoarthritis treatment. Tedalinab ...
|
T16928 |
SR144528
|
192703-06-3
|
98%
|
|
SR144528 is an effective and selective antagonist of the CB2 receptor (Ki: 0.6 nM).
|
T22009 |
CB2 receptor agonist 2
|
1314230-75-5
|
98%
|
|
CB2 receptor agonist 2 is a potent and selective agonist for the CB2 (cannabinoid type 2) receptor, Ki = 8.5 nM. CB2 receptor agonist 2 has high affinity and sel...
|
T21861 |
Drinabant
|
358970-97-5
|
98%
|
|
Drinabant is an orally active CB1 receptor antagonist. Drinabant inhibits the agonist-stimulated calcium signal with IC50 values of 25 nM and 10 nM for the hCB1-...
|
T14302 |
Olorinab
|
1268881-20-4
|
98%
|
|
Olorinab (APD 371) is a highly potent, selective and fully efficacious cannabinoid receptor type 2 (CB2) agonist. With an EC50 of 6.2 nM for hCB2.
|
T13289 |
EHP-101
|
1818428-24-8
|
|
|
VCE-004.8 is a specific dual agonist of PPARγ and CB2 receptor with potent anti-inflammatory activity. VCE-004.8 attenuates adipogenesis and prevents diet-induc...
|
T8511 |
TM38837
|
1253641-65-4
|
100%
|
|
TM38837 is an antagonist of cannabinoid receptor type 1 (CB1), with potential for the treatment of obesity and type 2 diabetes.
|
TN3575 |
(±)-Cannabichromene
|
20675-51-8
|
96.89%
|
|
Cannabichromene is a major non-psychotropic phytocannabinoid that inhibits endocannabinoid inactivation and activates the transient receptor potential ankyrin-1 ...
|
T9114 |
β-Caryophyllene
|
87-44-5
|
97.31%
|
|
β-Caryophyllene acts as an CB2 receptor agonist.
|
T1915 |
AM251
|
183232-66-8
|
97.88%
|
|
AM251 is a effective CB1 receptor antagonist (IC50/Ki: 8 /7.49 nM) that displays 306-fold selectivity over CB2 receptors; also effective GPR55 agonist (EC50: 39 ...
|
T2635 |
Org 27569
|
868273-06-7
|
98%
|
|
Org 27569, an allosteric modulator of cannabinoid CB1 receptor, can induce a CB1 receptor state that is characterized by decreased inverse agonist affinity and e...
|
T5996 |
CB1-IN-1
|
1429239-98-4
|
98%
|
|
CB1-IN-1 is a peripherally restricted CB1R antagonist, for CB1R and CB2R with Ki of 0.3 nM and 21 nM,respectively.
|
T7375 |
A-836339
|
959746-77-1
|
98%
|
|
A-836339 acts as a potent cannabinoid receptor full agonist which has a higher affinity for the peripheral CB2 receptor (Ki = 0.64 nM) over the central CB1 recep...
|
T28468 |
PSNCBAM-1
|
877202-74-9
|
98.18%
|
|
PSNCBAM-1 is a CB1 receptor negative allosteric modulator (EC50 = 0.1 μM) with hypophagic effects in vivo. PSNCBAM-1 can be used for obesity studies.
|
T7316 |
LY2828360
|
1231220-79-3
|
98.61%
|
|
LY2828360 is a cannabinoid (CB) receptor 2 agonist (Ki = 40.3 nM). It selectively activates CB2 over CB1 in a GTPγS binding assay (EC50s = 20.1 and >100,000 nM, ...
|